1. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy
   Anita Mangia et al, 2015, Cancer Biology & Therapy CrossRef
2. Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome
   Gisha Rose Antony et al, 2022, Clinical and Experimental Medicine CrossRef
3. Nrf2/P–glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer
   Mohammad Reza Sadeghi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
4. PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
   Shengwei Liu et al, 2017, Oncotarget CrossRef
5. Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancer
   Shigeyuki Tamari et al, 2022, Oncology Reports CrossRef
6. Differential expression of multidrug resistance-related proteins in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91) human bladder cancer cell lines
   Man Zhao et al, 2016, Molecular Medicine Reports CrossRef
7. Recent strategies to overcome breast cancer resistance
   Muhammad Muzamil Khan et al, 2024, Critical Reviews in Oncology/Hematology CrossRef